American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson Controls International
JCI
|
+$488M |
| 2 |
Microsoft
MSFT
|
+$266M |
| 3 |
Walmart Inc
WMT
|
+$264M |
| 4 |
Wells Fargo
WFC
|
+$224M |
| 5 |
BHI
Baker Hughes
BHI
|
+$212M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TotalEnergies
TTE
|
+$982M |
| 2 |
TYC
TYCO INTL PLC COM SHS (IRL)
TYC
|
+$390M |
| 3 |
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
|
+$242M |
| 4 |
Cognizant
CTSH
|
+$212M |
| 5 |
Air Products & Chemicals
APD
|
+$210M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.66% |
| 2 | Healthcare | 13.23% |
| 3 | Technology | 11.14% |
| 4 | Consumer Discretionary | 10.99% |
| 5 | Industrials | 10.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SAND
1076
DELISTED
Sandstorm Gold
SAND
| $1.74M | ﹤0.01% |
345,000
| – | – |
|
1077
NMI Holdings
NMIH
$3.38B
| $1.73M | ﹤0.01% |
226,879
+44,803
| +25% | +$314K |
|
1078
Broadridge
BR
$19.3B
| $1.73M | ﹤0.01% |
+25,446
| New | +$1.74M |
|
1079
MiMedx Group
MDXG
$624M
| $1.72M | ﹤0.01% |
200,751
-116,308
| -37% | -$921K |
|
1080
OneSpan
OSPN
$609M
| $1.72M | ﹤0.01% |
97,716
-95,672
| -49% | -$1.68M |
|
|
VRTV
1081
DELISTED
VERITIV CORPORATION
VRTV
| $1.72M | ﹤0.01% |
34,292
+14,013
| +69% | +$648K |
|
|
PETX
1082
DELISTED
Aratana Therapeutics, Inc.
PETX
| $1.72M | ﹤0.01% |
+183,617
| New | +$1.52M |
|
1083
Comscore
SCOR
$108M
| $1.7M | ﹤0.01% |
2,770
+197
| +8% | +$112K |
|
|
B
1084
DELISTED
Barnes Group Inc.
B
| $1.63M | ﹤0.01% |
+40,091
| New | +$1.56M |
|
|
NXTM
1085
DELISTED
NxStage Medical Inc.
NXTM
| $1.62M | ﹤0.01% |
64,927
+3,643
| +6% | +$84.9K |
|
1086
Gold Fields
GFI
$36.4B
| $1.61M | ﹤0.01% |
331,995
+32,995
| +11% | +$187K |
|
|
FLXN
1087
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $1.61M | ﹤0.01% |
+82,262
| New | +$1.39M |
|
|
BSTC
1088
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $1.6M | ﹤0.01% |
35,100
-21,235
| -38% | -$853K |
|
|
UFS
1089
DELISTED
DOMTAR CORPORATION (New)
UFS
| $1.59M | ﹤0.01% |
42,963
+383
| +0.9% | +$14.1K |
|
|
INSY
1090
DELISTED
Insys Therapeutics, Inc.
INSY
| $1.59M | ﹤0.01% |
135,063
-146,903
| -52% | -$2.23M |
|
1091
Dine Brands
DIN
$462M
| $1.57M | ﹤0.01% |
19,876
+1,421
| +8% | +$113K |
|
1092
Ligand Pharmaceuticals
LGND
$5.85B
| $1.57M | ﹤0.01% |
24,614
-97,387
| -80% | -$7.15M |
|
1093
ATN International
ATNI
$478M
| $1.57M | ﹤0.01% |
24,077
-1,031
| -4% | -$72.7K |
|
|
DERM
1094
DELISTED
Dermira, Inc.
DERM
| $1.56M | ﹤0.01% |
46,100
-138
| -0.3% | -$4.45K |
|
1095
Vanda Pharmaceuticals
VNDA
$314M
| $1.54M | ﹤0.01% |
+92,700
| New | +$1.25M |
|
1096
Gibraltar Industries
ROCK
$1.46B
| $1.54M | ﹤0.01% |
41,513
+2,952
| +8% | +$108K |
|
|
AIMT
1097
DELISTED
Aimmune Therapeutics
AIMT
| $1.53M | ﹤0.01% |
102,033
+3,772
| +4% | +$50.9K |
|
1098
First Majestic Silver
AG
$9.44B
| $1.52M | ﹤0.01% |
147,800
+45,400
| +44% | +$665K |
|
|
AGTC
1099
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $1.52M | ﹤0.01% |
155,421
+17,801
| +13% | +$240K |
|
1100
DTE Energy
DTE
$28.9B
| $1.52M | ﹤0.01% |
19,014
| – | – |
|
Similar funds
American Century Companies's Q3 2016 Portfolio in Review
As of Q3 2016, American Century Companies held 1,492 positions worth $91B, up 3.5% from $88B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
American Century Companies's Q3 2016 filing shows 168 new, 559 increased, 548 reduced and 172 closed positions. Its largest new stake was Johnson Controls International: 10,534,565 shares worth $490M. The largest sale was TotalEnergies, an estimated $982M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Technology.
- American Century Companies's largest Q3 2016 buy was Johnson Controls International: 10,534,565 shares worth $490M.
- American Century Companies added most to Microsoft in Q3 2016, an estimated $266M increase.
- American Century Companies's biggest Q3 2016 reduction was TotalEnergies, cutting an estimated $982M.
- American Century Companies fully exited TYCO INTL PLC COM SHS (IRL) in Q3 2016, selling an estimated $390M.
- American Century Companies's ten largest holdings make up 14% of its $91B portfolio in Q3 2016.
- American Century Companies opened 168 new positions and closed 172 in Q3 2016.
- American Century Companies's portfolio value rose 3.5% quarter-over-quarter to $91B.
Based on American Century Companies's 13F filing for Q3 2016, filed 1 Nov 2016.